Haggstrom Anita N, Drolet Beth A, Baselga Eulalia, Chamlin Sarah L, Garzon Maria C, Horii Kimberly A, Lucky Anne W, Mancini Anthony J, Metry Denise W, Newell Brandon, Nopper Amy J, Frieden Ilona J
Department of Dermatology, University of California, San Francisco, California, USA.
Pediatrics. 2006 Sep;118(3):882-7. doi: 10.1542/peds.2006-0413.
Infantile hemangiomas are the most common tumor of infancy. Risk factors for complications and need for treatment have not been studied previously in a large prospective study. This study aims to identify clinical characteristics associated with complications and the need for therapeutic intervention.
We conducted a prospective cohort study at 7 US pediatric dermatology clinics with a consecutive sample of 1058 children, aged < or = 12 years, with infantile hemangiomas enrolled between September 2002 and October 2003. A standardized questionnaire was used to collect data on each patient and each hemangioma, including clinical characteristics, complications, and treatment.
Twenty-four percent of patients experienced complications related to their hemangioma(s), and 38% of our patients received some form of treatment during the study period. Hemangiomas that had complications and required treatment were larger and more likely to be located on the face. Segmental hemangiomas were 11 times more likely to experience complications and 8 times more likely to receive treatment than localized hemangiomas, even when controlled for size.
Large size, facial location, and/or segmental morphology are the most important predictors of poor short-term outcomes as measured by complication and treatment rates.
婴儿血管瘤是婴儿期最常见的肿瘤。此前尚未在大型前瞻性研究中对并发症的危险因素及治疗需求进行研究。本研究旨在确定与并发症及治疗干预需求相关的临床特征。
我们在美国7家儿科皮肤科诊所进行了一项前瞻性队列研究,连续纳入了2002年9月至2003年10月期间年龄小于或等于12岁、患有婴儿血管瘤的1058名儿童。使用标准化问卷收集每位患者及每个血管瘤的数据,包括临床特征、并发症和治疗情况。
24%的患者出现了与血管瘤相关的并发症,38%的患者在研究期间接受了某种形式的治疗。出现并发症且需要治疗的血管瘤更大,且更有可能位于面部。即使在控制了大小因素后,节段性血管瘤出现并发症的可能性是局限性血管瘤的11倍,接受治疗的可能性是局限性血管瘤的8倍。
就并发症和治疗率而言,大尺寸、面部位置和/或节段性形态是短期预后不良的最重要预测因素。